Survival of patients after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis

Autor: Isaacs, JD, Clarke, AM, Hazleman, BL, Hale, G, Waldmann, H, Symmons, DPM

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::7f5114607e1166df7ca272a259e60cba
https://ora.ox.ac.uk/objects/uuid:e2a9a3e7-a047-4151-81dd-5e0df84b1463

Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial

Autor: Tak, Pp, Rigby, Wf, Rubbert Roth, A, Peterfy, Cg, van Vollenhoven RF, Stohl, W, Hessey, E, Chen, A, Tyrrell, H, Shaw, Tm, Aelion J, IMAGE I. n. v. e. s. t. i. g. a. t. o. r. s., Afif, N, Ahmadi, F, Aires, F, Alanis, E, Alonso, Cs, Alten, Rh, Alvaro Gracia JM, Ashrafzadeh, A, Ballina, J, Bambara, Lm, Bao, C, Bell, M, Berney, S, Bessette, L, Birbara, C, Boling, E, Bourgeois, P, Braun, J, Briones, H, Brzezicki, J, Burgos Vargos, R, Burmester, G, Burnett, M, Busch, H, Cabello, E, Calvo, A, Cantagrel, A, Cantini, F, Zea, Ac, Carreño Perez, L, Chavez, J, Shim, Sc, Chindalore, V, Chiriac, R, Codding, C, Danda, D, Del Guidice, J, De Vita, S, Digiovanni, R, Dikranian, A, Eider, W, Fantini, F, Ferraccioli, G, Fietchner, J, Filipowicz Sosnowska, A, Finnanger, B, Fiocco, G, Fleck, M, Fleischmann, R, Fraser, A, Gaudin, P, Gauler, G, Gaylis, N, Gerlag, Dm, Godde, J, Gomez Reino JJ, Gornisiewicz, M, Gough, W, Greenwald, M, Guerra, G, Hackshaw, K, Haentzschel, Hm, Hammond, T, Hazleman, Bl, Heilig, B, Herenius, Mm, Hilliquin, P, Holt, D, Huang, F, Huff, J, Huizinga, T, Isaacs, J, Jaffer, A, Amante, Ej, Jeka, S, Jimenez, R, Jones, G, Jones, R, Kaine, J, Kashif, A, Kaufmann, C, Kay, J, Khraishi, M, Kivitz, A, Klinkhoff, A, Kraag, G, Krystufkova, O, Kucharz, E, Lawson, J, Leirisalo Repo, M, Levin, R, Liang, G, Liang, P, Limonta, M, Lowenstein, M, Rodriguez Lozano, C, Lue, C, Mahowald, M, Maradiaga, M, Maricic, M, Mariette, X, Martin, L, Massarotti, E, Matucci Cerinic, M, Montecucco, Cm, Mazurov, V, Mcnally, J, Mehta, D, Meyer, O, Misra, R, Moreland, Lw, Mueller Ladner, U, Myerson, G, Nasonov, E, Navarra, S, Navarro, F, Neal, N, Olech, E, Olsen, N, Pablos, Jl, Pacheco, C, Pal, S, Palomo, Er, Pandith, V, Penserga, Eg, Prupas, H, Radominski, S, Ramos Remus, C, Reid, D, Riordan, K, Rosenberg, D, Ruiz, A, Saadeh, C, Salvarani, Carlo, Samuels, A, Sanmarti, R, Sarzi Puttini, P, Saxe, P, Schechtman, J, Scoville, C, Sedlackova, M, Sedrish, M, Sejer Hansen, M, Sibilia, J, Siebert, S, Specker, C, Stern, S, Szechinski, J, Tahir, H, Taylor, A, Thompson, Pw, Tony, Hp, Tornero, J, Trapp, R, Tremblay, Jl, Valesini, G, Van Den Bosch, F, Wanchu, A, Wassenberg, S, Ximenes, Ac, Kim, Hy, Zanetakis, E, Zazueta, B, Zerbini, C.

Publikováno v: Annals of the Rheumatic Diseases, 70(1), 39-46. BMJ Publishing Group
Annals of the rheumatic diseases, 70(1), 39-46. BMJ Publishing Group

Objectives: Rituximab is an effective treatment in patients with established rheumatoid arthritis (RA). The objective of the IMAGE study was to determine the efficacy of rituximab in the prevention of joint damage and its safety in combination with m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c80a94d92fa815c8602c1c10bf00fd4d
https://doi.org/10.1136/ard.2010.137703

Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR)

Autor: Rubbert Roth, Andrea, Tak, Paul P, Zerbini, Cristiano, Tremblay, Jean Luc, Carreño, Luis, Armstrong, Gillian, Collinson, Neil, Shaw, Tim M, MIRROR Trial Investigators, Nash, P, Bagga, H, Hall, S, Littlejohn, G, Manolios, N, Van Den Bosch, F, Ximenes, Ac, Mccarthy, T, Atkins, C, Thorne, Jc, Offer, R, Pope, J, Keystone, E, Huang, F, Wu, D, Karjalainen, A, Schaeverbeke, T, Euller Ziegler, L, Jorgensen, C, Nguyen, M, Puechal, X, Wassenberg, S, Heilig, B, Mueller Ladner, U, Wollenhaupt, J, Braun, J, Gauler, G, Szekanecz, Z, Nagy, K, Galeazzi, M, Trotta, F, Bombardieri, S, Salvarani, Carlo, Pellerito, R, Seriolo, B, Adami, S, Bianchi, G, Giacomelli, R, Arioli, G, Cantini, F, Ching, D, Gilchrist, N, Singh, J, Lukac, J, Rovensky, J, Macejova, Z, Kalla, A, Tikly, M, Ally, Mm, Marenco, Jl, Tinture, T, Juanola, J, Alvaro Gracia JM, Rodriguez Heredia JM, Sandoval, Tp, Cheng, Tt, Luo, Sf, Lan, Jl, Osiri, M, Nilganuwong, S, Asavatanabodee, P, Nanagara, R, Louthrenoo, W, Hazleman, Bl, Jubb, R, George, E, Hakim, A, Grennan, D, Gardiner, P, Taylor, J, Mcnally, J, Hutchinson, D, Plant, M.

Publikováno v: Rheumatology (Oxford, England)
Rheumatology (Oxford, England), 49(9), 1683-1693. Oxford University Press

Objective. To evaluate the efficacy and safety of three dosing and repeat treatment regimens of rituximab (RTX) plus MTX in patients with active RA. Methods. Patients with active RA despite stable MTX (10–25 mg/week) were randomly assigned to one o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a41b182bf39f344987bb981fdd06fa7
https://hdl.handle.net/11380/1079787

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.